title: [Fibrocystic mastopathy and cancer of the breast. About 111 cases].
abstract: OBJECTIVE
  Our aim was to identify the predictive factors of degeneration of the fibrocystic mastopathy.
  
  
  METHODS
  This work is a retrospective survey of 111 observations of isolated fibrocystic mastopathies or associated to a breast cancer among 542 women admitted for tumor of the breast during one period of 13 active years from 1991 to 2003. The diagnosis has been gotten by anatomo-pathologic exam in 95.5% (106 cas) on the operative piece and 4.5% (5 cas) on a material of biopsy.
  
  
  RESULTS
  The fibrocystic mastopathy represented 30% of the set of the benign tumors of the breast. They were associated to a breast cancer in 45 cases (40.5%). The isolated benign fibrocystic mastopathy was observed in 66 cases with a middle age of 37 years, whereas the shapes associated to a breast carcinoma were noted in 45 cases. The middle age was 53 years. The non proliferative fibrocystic mastopathy is the most frequent histological type and represent 54.6% of the cases. The proliferative form with atypies was observed at 21 women (46.8%). The carcinoma the more frequently associated to the fibrocystic mastopathy was the infiltrating canalled carcinoma in 91% of cases, with a predominance of the II rank (SBR).
  
  
  CONCLUSIONS
  The discovery of a mastopathy must search a luteal failure and risk factors of breast cancer notably a proliferative shape of mastopathy with atypies.
authors.affiliation: Service de Chirurgie Génrale, EPS Habib Bomurgiiba, Sfax, Tunisie.
authors.forename: Mohamed Issam
authors.initials: MI
authors.lastname: Beyrouti
authors.forename: Ramez
authors.initials: R
authors.lastname: Beyrouti
authors.forename: Abdelmajid
authors.initials: A
authors.lastname: Khabir
authors.forename: Mohamed
authors.initials: M
authors.lastname: Ben Amar
authors.forename: Foued
authors.initials: F
authors.lastname: Frikha
authors.forename: Nabil
authors.initials: N
authors.lastname: Dhieb
authors.forename: Dalel
authors.initials: D
authors.lastname: Damak
authors.forename: Mohamed
authors.initials: M
authors.lastname: Abid
authors.forename: Najmeddine
authors.initials: N
authors.lastname: Affes
authors.forename: Salah
authors.initials: S
authors.lastname: Boujelben
authors.forename: Mounir
authors.initials: M
authors.lastname: Frikha
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D001706:Biopsy; D001940:Breast / Q000473:pathology; D001943:Breast Neoplasms / Q000150:complications / Q000175:diagnosis / Q000473:pathology; D018270:Carcinoma, Ductal, Breast / Q000150:complications / Q000175:diagnosis; D016009:Chi-Square Distribution; D003627:Data Interpretation, Statistical; D005260:Female; D005348:Fibrocystic Breast Disease / Q000145:classification / Q000150:complications / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009367:Neoplasm Staging; D010298:Parity; D011237:Predictive Value of Tests; D011247:Pregnancy; D012189:Retrospective Studies; D012306:Risk; D012307:Risk Factors; D016217:Ultrasonography, Mammary